查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1625168

到 2030 年生物製藥第三方物流預測：按服務類型、溫度類型、運輸模式、應用、最終用戶和地區進行全球分析

Biopharmaceutical Third-party Logistics Market Forecasts to 2030 - Global Analysis By Service Type, Temperature Type, Mode of Transport, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2024年全球生物製藥第三方物流（3PL）市場規模將達到1,252.4億美元，2030年將達到1,896.2億美元，預測期內複合年成長率為7.2%。

生物製藥第三方物流是指生物製藥公司將物流服務外包給專業供應商。這些供應商管理關鍵的供應鏈功能，例如倉儲、運輸、庫存管理和生物製藥分銷。透過利用第三方物流，公司可以降低成本、提高效率並專注於其核心競爭力，同時確保及時、安全地將產品交付給醫護人員和患者。

根據2021年7月進行的全球調查，第三方物流供應商的低溫運輸服務成長了62%。

生物製藥需求不斷成長

隨著全球醫療保健的發展，對處理溫度敏感的高價值產品的高效且合規的物流解決方案的需求不斷增加。 3PL 供應商提供低溫運輸物流、合規性和安全運輸等專業服務，以確保這些產品的完整性和安全性。此外，生物製藥製造的區域擴張增加了對可靠物流網路的需求。這種不斷成長的需求正在推動物流基礎設施的創新和投資，推動整體市場的擴張。

供應鏈中斷的風險

3PL 的供應鏈中斷風險源自於自然災害、地緣政治不穩定、勞動力短缺、運輸瓶頸和監管變化等因素。這些中斷可能導致藥物交付延遲、缺貨和溫度敏感產品變質。對於產品完整性至關重要的生物製藥來說，這些破壞可能會產生嚴重後果。這些風險會增加成本、影響服務可靠性並降低客戶信任，從而阻礙市場成長。

生物製藥產業的全球化

隨著生物製藥公司在全球擴張，對產品可靠性、合規性和及時交付的需求不斷成長。 3PL 供應商在管理複雜的供應鏈、確保法規遵循和處理對溫度敏感的藥品方面發揮關鍵作用。此外，隨著生技藥品、疫苗和臨床試驗材料跨境貿易的增加，3PL 供應商對於克服物流挑戰和滿足全球對生物製藥和市場不斷成長的需求至關重要。

保安和安全問題

3PL 中的安全問題源於生物藥品價格昂貴且敏感，這使得它們在運輸過程中容易被盜竊、偽造和損壞。對溫度敏感的藥物需要精確處理才能維持功效，任何偏差都會影響產品品質。此外，全球運輸可能面臨詐騙、貨物竊盜和竄改等風險。這些擔憂增加了安全措施、監管合規和保險等營運成本，阻礙了市場成長。

COVID-19 的影響

COVID-19大流行增加了對溫度敏感藥物（尤其是疫苗）的配送需求，對生物製藥第三方物流市場產生了重大影響。全球醫療保健需求的激增導致供應鏈緊張，並凸顯了強大的物流解決方案的重要性。儘管運輸中斷、勞動力短缺和邊境限制帶來了挑戰，但疫情加速了數位技術的採用，以追蹤和管理貨運。總體而言，COVID-19 凸顯了生物製藥產業對有彈性、高效且合規的 3PL 服務的需求。

預計在預測期內，倉儲業將是最大的。

預計倉儲業將在整個預測期內獲得最大的市場佔有率。生物醫藥第三方物流倉儲包括溫度敏感藥物、生技藥品、疫苗等醫藥產品的儲存。倉儲服務對於維持生物製藥的品質、安全性和有效性至關重要。生技藥品的成長和全球分銷正在推動對安全、合規和高效倉儲解決方案的需求。

預計臨床試驗和樣本部分在預測期內複合年成長率最高。

預計臨床試驗和樣本部分在預測期內複合年成長率最高。 3PL 提供者確保遵守良好的分銷實踐和溫度控制要求，這對於維持臨床實驗藥物的完整性和有效性至關重要。這些服務包括安全包裝、低溫運輸物流以及及時運送到世界各地的臨床實驗地點。隨著臨床試驗在全球擴展，3PL 在臨床材料的高效、合規且經濟高效的管理方面發揮關鍵作用。

比最大的地區

由於對生物製藥（尤其是疫苗和生技藥品）的需求不斷成長以及對醫療保健基礎設施的投資增加，預計亞太地區將在預測期內創下最大的市場佔有率。市場的主要參與者包括 DHL Supply Chain、Kuehne+Nagel、DB Schenker、XPO Logistics 等。該地區快速的都市化和監管發展進一步推動了市場的成長。隨著低溫運輸物流需求的增加，亞太地區3PL市場預計將大幅成長，為物流供應商提供新的商機。

複合年成長率最高的地區：

由於北美地區注重監管合規性，預計在預測期內複合年成長率最高。該地區擁有完善的醫療保健基礎設施，生技藥品和生物相似藥的成長進一步推動了市場。該地區的主要企業包括 FedEx、UPS、XPO Logistics 和 Kuehne+Nagel。隨著對低溫運輸物流的日益關注，在對高效、合規的生物製藥分銷解決方案的需求的推動下，北美 3PL 市場預計將出現強勁成長。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球生物製藥第三方物流市場：依服務類型

  • 運輸管理
  • 倉儲
  • 庫存管理
  • 包裹
  • 訂單履行
  • 報關
  • 退貨管理
  • 其他服務類型

第6章全球生物製藥第三方物流市場：依溫度類型

  • 環境的
  • 低溫運輸
  • 冷凍的
  • 其他溫度類型

第7章 全球生物製藥第三方物流市場：依運輸方式分類

  • 道路運輸
  • 鐵路運輸
  • 空運
  • 海運

第8章全球生物製藥第三方物流市場：依應用

  • 低溫運輸物流
  • 非低溫運輸物流
  • 臨床試驗和樣品
  • 成品
  • 其他用途

第9章全球生物製藥第三方物流市場：依最終用戶分類

  • 藥品製造商
  • 生技公司
  • 合約藥物開發業務（CRO）
  • 藥品契約製造(CMO)
  • 醫療服務提供方
  • 其他最終用戶

第10章全球生物製藥第三方物流市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章 公司概況

  • DHL Supply Chain
  • Kuehne+Nagel
  • UPS Supply Chain Solutions
  • FedEx Supply Chain
  • XPO Logistics
  • CH Robinson Worldwide
  • DB Schenker
  • Expeditors International
  • Hellmann Worldwide Logistics
  • Sinotrans Limited
  • DSV A/S
  • Agility Logistics
  • Seino Transportation
  • Ceva Logistics
  • Alcami Corporation
Product Code: SMRC28121

According to Stratistics MRC, the Global Biopharmaceutical Third-party Logistics Market is accounted for $125.24 billion in 2024 and is expected to reach $189.62 billion by 2030 growing at a CAGR of 7.2% during the forecast period. Biopharmaceutical third-party logistics refers to the outsourcing of logistics services by biopharmaceutical companies to specialized providers. These providers manage key supply chain functions such as warehousing, transportation, inventory management, and distribution of biopharmaceutical products. By leveraging third-party logistics, companies can reduce costs, improve efficiency, and focus on their core competencies while ensuring timely and safe delivery of products to healthcare providers and patients.

According to a global survey carried out in July 2021, cold chain services by third-party logistics providers raised by 62%.

Market Dynamics:

Driver:

Rising demand for biopharmaceutical products

As the global healthcare landscape evolves, the need for efficient and compliant logistics solutions to handle temperature-sensitive and high-value products increases. 3PL providers offer specialized services such as cold chain logistics, regulatory compliance, and secure transportation, ensuring the integrity and safety of these products. Additionally, the expansion of biopharmaceutical manufacturing across regions boosts the need for reliable distribution networks. This growing demand drives innovation and investment in logistics infrastructure, fostering the market's overall expansion.

Restraint:

Risk of supply chain disruptions

The risk of supply chain disruptions in 3PL arises from factors like natural disasters, geopolitical instability, labor shortages, transportation bottlenecks, and regulatory changes. These disruptions can lead to delays in drug delivery, stockouts, and spoilage of temperature-sensitive products. For biopharmaceuticals, where product integrity is critical, such interruptions can have serious consequences. These risks hinder market growth by increasing costs, impacting service reliability, and reducing customer trust.

Opportunity:

Globalization of the biopharmaceutical industry

With the rising global footprint of biopharmaceutical companies, the demand for reliable, compliant, and timely delivery of products rises. 3PL providers play a crucial role in managing complex supply chains, ensuring regulatory adherence, and handling temperature-sensitive drugs. Furthermore, with the rise in cross-border trade of biologics, vaccines, and clinical trial materials, 3PL providers are essential for overcoming logistical challenges and meeting the growing global demand for biopharmaceutical products, fostering market growth.

Threat:

Security and safety concerns

Security and safety concerns in 3PL arise from the high value and sensitivity of biopharmaceutical products, which are vulnerable to theft, counterfeiting, and damage during transit. Temperature-sensitive drugs require precise handling to maintain efficacy, and any deviation can compromise product quality. Additionally, global transportation can face risks from fraud, cargo theft, or tampering. These concerns hamper market growth by increasing operational costs for security measures, regulatory compliance and insurance.

Covid-19 Impact

The covid-19 pandemic significantly impacted the biopharmaceutical third-party logistics market by increasing demand for temperature-sensitive drug distribution, especially vaccines. The surge in global healthcare needs strained supply chains, highlighting the importance of robust logistics solutions. While disruptions in transportation, labor shortages, and border restrictions posed challenges, the pandemic also accelerated the adoption of digital technologies for tracking and managing shipments. Overall, COVID-19 emphasized the need for resilient, efficient, and compliant 3PL services in the biopharmaceutical industry.

The warehousing segment is expected to be the largest during the forecast period

The warehousing segment is predicted to secure the largest market share throughout the forecast period. Warehousing in biopharmaceutical third-party logistics involves the storage of pharmaceutical products, including temperature-sensitive drugs, biologics, and vaccines. Warehousing services are critical for maintaining the quality, safety, and efficacy of biopharmaceuticals. The growth of biologics and global distribution has expanded the demand for secure, compliant, and efficient warehousing solutions.

The clinical trials & samples segment is expected to have the highest CAGR during the forecast period

The clinical trials & samples segment is anticipated to witness the highest CAGR during the forecast period. 3PL providers ensure compliance with good distribution practice and temperature control requirements, crucial for maintaining the integrity and efficacy of trial materials. These services include secure packaging, cold chain logistics, and timely delivery to trial sites worldwide. As clinical trials expand globally, 3PL plays a vital role in efficient, compliant, and cost-effective management of clinical materials.

Region with largest share:

Asia Pacific is expected to register the largest market share during the forecast period driven by growing demand for biopharmaceuticals, especially vaccines and biologics, along with increasing investments in healthcare infrastructure. Key players in this market include DHL Supply Chain, Kuehne + Nagel, DB Schenker, and XPO Logistics. The region's rapid urbanization and regulatory advancements further support market growth. As demand for cold chain logistics rises, the Asia-Pacific 3PL market is expected to grow significantly, offering new opportunities for logistics providers.

Region with highest CAGR:

North America is expected to witness the highest CAGR over the forecast period fuelled by its strong emphasis on regulatory compliance. The region's well-established healthcare infrastructure and the growth of biologics and biosimilars further propel the market. Key players in the region include FedEx, UPS, XPO Logistics, and Kuehne + Nagel. With an expanding focus on cold chain logistics, North America's 3PL market is expected to experience steady growth, driven by the need for efficient and compliant biopharmaceutical distribution solutions.

Key players in the market

Some of the key players profiled in the Biopharmaceutical Third-party Logistics Market include DHL Supply Chain, Kuehne + Nagel, UPS Supply Chain Solutions, FedEx Supply Chain, XPO Logistics, C.H. Robinson Worldwide, DB Schenker, Expeditors International, Hellmann Worldwide Logistics, Sinotrans Limited, DSV A/S, Agility Logistics, Seino Transportation, Ceva Logistics and Alcami Corporation.

Key Developments:

In January 2024, Alcami Corporation opened a new 65,000 ft2 pharmaceutical storage and services facility in Garner, North Carolina, strategically located near the Research Triangle Park (RTP), a major biotech and pharmaceutical hub. This state-of-the-art facility is part of Alcami's plan to enhance its contract development and manufacturing services, providing specialized storage solutions for biotech and pharmaceutical clients.

In August 2023, CEVA Logistics expanded its operations in India by acquiring 96% of Stellar Value Chain Solutions, a Mumbai-based provider of contract logistics and omni-channel fulfilment services. This strategic acquisition enhances CEVA's presence in India, adding over 60 locations across 35 cities. The deal also boosts CEVA's capabilities in sectors like e-commerce, automotive, consumer products, and pharmaceuticals.

Service Types Covered:

  • Transportation Management
  • Warehousing
  • Inventory Management
  • Packaging
  • Order Fulfillment
  • Customs Clearance
  • Returns Management
  • Other Service Types

Temperature Types Covered:

  • Ambient
  • Cold Chain
  • Frozen
  • Other Temperature Types

Mode of Transports Covered:

  • Road Transport
  • Rail Transport
  • Air Transport
  • Sea Transport

Applications Covered:

  • Cold Chain Logistics
  • Non-Cold Chain Logistics
  • Clinical Trials & Samples
  • Finished Goods
  • Other Applications

End Users Covered:

  • Pharmaceutical Manufacturers
  • Biotech Companies
  • Contract Research Organizations (CROs)
  • Contract Manufacturing Organizations (CMOs)
  • Healthcare Providers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biopharmaceutical Third-party Logistics Market, By Service Type

  • 5.1 Introduction
  • 5.2 Transportation Management
  • 5.3 Warehousing
  • 5.4 Inventory Management
  • 5.5 Packaging
  • 5.6 Order Fulfillment
  • 5.7 Customs Clearance
  • 5.8 Returns Management
  • 5.9 Other Service Types

6 Global Biopharmaceutical Third-party Logistics Market, By Temperature Type

  • 6.1 Introduction
  • 6.2 Ambient
  • 6.3 Cold Chain
  • 6.4 Frozen
  • 6.5 Other Temperature Types

7 Global Biopharmaceutical Third-party Logistics Market, By Mode of Transport

  • 7.1 Introduction
  • 7.2 Road Transport
  • 7.3 Rail Transport
  • 7.4 Air Transport
  • 7.5 Sea Transport

8 Global Biopharmaceutical Third-party Logistics Market, By Application

  • 8.1 Introduction
  • 8.2 Cold Chain Logistics
  • 8.3 Non-Cold Chain Logistics
  • 8.4 Clinical Trials & Samples
  • 8.5 Finished Goods
  • 8.6 Other Applications

9 Global Biopharmaceutical Third-party Logistics Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical Manufacturers
  • 9.3 Biotech Companies
  • 9.4 Contract Research Organizations (CROs)
  • 9.5 Contract Manufacturing Organizations (CMOs)
  • 9.6 Healthcare Providers
  • 9.7 Other End Users

10 Global Biopharmaceutical Third-party Logistics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 DHL Supply Chain
  • 12.2 Kuehne + Nagel
  • 12.3 UPS Supply Chain Solutions
  • 12.4 FedEx Supply Chain
  • 12.5 XPO Logistics
  • 12.6 C.H. Robinson Worldwide
  • 12.7 DB Schenker
  • 12.8 Expeditors International
  • 12.9 Hellmann Worldwide Logistics
  • 12.10 Sinotrans Limited
  • 12.11 DSV A/S
  • 12.12 Agility Logistics
  • 12.13 Seino Transportation
  • 12.14 Ceva Logistics
  • 12.15 Alcami Corporation

List of Tables

  • Table 1 Global Biopharmaceutical Third-party Logistics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Biopharmaceutical Third-party Logistics Market Outlook, By Service Type (2022-2030) ($MN)
  • Table 3 Global Biopharmaceutical Third-party Logistics Market Outlook, By Transportation Management (2022-2030) ($MN)
  • Table 4 Global Biopharmaceutical Third-party Logistics Market Outlook, By Warehousing (2022-2030) ($MN)
  • Table 5 Global Biopharmaceutical Third-party Logistics Market Outlook, By Inventory Management (2022-2030) ($MN)
  • Table 6 Global Biopharmaceutical Third-party Logistics Market Outlook, By Packaging (2022-2030) ($MN)
  • Table 7 Global Biopharmaceutical Third-party Logistics Market Outlook, By Order Fulfillment (2022-2030) ($MN)
  • Table 8 Global Biopharmaceutical Third-party Logistics Market Outlook, By Customs Clearance (2022-2030) ($MN)
  • Table 9 Global Biopharmaceutical Third-party Logistics Market Outlook, By Returns Management (2022-2030) ($MN)
  • Table 10 Global Biopharmaceutical Third-party Logistics Market Outlook, By Other Service Types (2022-2030) ($MN)
  • Table 11 Global Biopharmaceutical Third-party Logistics Market Outlook, By Temperature Type (2022-2030) ($MN)
  • Table 12 Global Biopharmaceutical Third-party Logistics Market Outlook, By Ambient (2022-2030) ($MN)
  • Table 13 Global Biopharmaceutical Third-party Logistics Market Outlook, By Cold Chain (2022-2030) ($MN)
  • Table 14 Global Biopharmaceutical Third-party Logistics Market Outlook, By Frozen (2022-2030) ($MN)
  • Table 15 Global Biopharmaceutical Third-party Logistics Market Outlook, By Other Temperature Types (2022-2030) ($MN)
  • Table 16 Global Biopharmaceutical Third-party Logistics Market Outlook, By Mode of Transport (2022-2030) ($MN)
  • Table 17 Global Biopharmaceutical Third-party Logistics Market Outlook, By Road Transport (2022-2030) ($MN)
  • Table 18 Global Biopharmaceutical Third-party Logistics Market Outlook, By Rail Transport (2022-2030) ($MN)
  • Table 19 Global Biopharmaceutical Third-party Logistics Market Outlook, By Air Transport (2022-2030) ($MN)
  • Table 20 Global Biopharmaceutical Third-party Logistics Market Outlook, By Sea Transport (2022-2030) ($MN)
  • Table 21 Global Biopharmaceutical Third-party Logistics Market Outlook, By Application (2022-2030) ($MN)
  • Table 22 Global Biopharmaceutical Third-party Logistics Market Outlook, By Cold Chain Logistics (2022-2030) ($MN)
  • Table 23 Global Biopharmaceutical Third-party Logistics Market Outlook, By Non-Cold Chain Logistics (2022-2030) ($MN)
  • Table 24 Global Biopharmaceutical Third-party Logistics Market Outlook, By Clinical Trials & Samples (2022-2030) ($MN)
  • Table 25 Global Biopharmaceutical Third-party Logistics Market Outlook, By Finished Goods (2022-2030) ($MN)
  • Table 26 Global Biopharmaceutical Third-party Logistics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 27 Global Biopharmaceutical Third-party Logistics Market Outlook, By End User (2022-2030) ($MN)
  • Table 28 Global Biopharmaceutical Third-party Logistics Market Outlook, By Pharmaceutical Manufacturers (2022-2030) ($MN)
  • Table 29 Global Biopharmaceutical Third-party Logistics Market Outlook, By Biotech Companies (2022-2030) ($MN)
  • Table 30 Global Biopharmaceutical Third-party Logistics Market Outlook, By Contract Research Organizations (CROs) (2022-2030) ($MN)
  • Table 31 Global Biopharmaceutical Third-party Logistics Market Outlook, By Contract Manufacturing Organizations (CMOs) (2022-2030) ($MN)
  • Table 32 Global Biopharmaceutical Third-party Logistics Market Outlook, By Healthcare Providers (2022-2030) ($MN)
  • Table 33 Global Biopharmaceutical Third-party Logistics Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.